Project Grant K01DA065837
Award Date 7/1/26
Completion Date 6/30/31
Dollars Obligated $193K
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Minneapolis, MN 55415, USA
Similar Awards
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $197,624 Project Grant to The Johns Hopkins University, effective April 15, 2026 through March 31, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). This K01 Career Development Award supports research aimed at identifying and leveraging social network dynamics to improve treatment engagement and health outcomes for parents who misuse opioids and have dependent children (PWUO-DC). The project...
- Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded Indiana University Indianapolis a Project Grant of $169,167 under the Drug Use and Addiction Research Programs (CFDA 93.279) on May 1, 2026, with a completion date of April 30, 2031. This mentored career development award supports research to improve access to high-quality adolescent opioid use disorder (OUD) and substance use disorder (SUD) services in primary care settings. The project addresses the rising adolescent...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Project Grant totaling $144,252 to the University of Massachusetts Medical School under the Drug Use and Addiction Research Programs (CFDA 93.279) effective September 1, 2025, through August 31, 2030. Dr. Carreiro will leverage her expertise in personalized medicine approaches to opioid use disorder (OUD) to develop a mentoring program that creates training opportunities for early-career scientists in medical...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a Mentored Research Scientist Development Award (K01) of $399,600 on August 15, 2025, to support a five-year career development and mentored research program under the Drug Use and Addiction Research Programs (CFDA 93.279). Led by Dr. Jason Brian Gibbons at the University of Colorado Anschutz Medical Campus, the award funds the development of dynamic, personalized treatment recommendations for opioid use...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded The Miriam Hospital a K01 Career Development Award totaling $186,895 under the Drug Use and Addiction Research Programs (CFDA 93.279) effective May 1, 2026, through April 30, 2031. This award supports research to identify optimal treatment and prevention service delivery models for people who use drugs with infectious disease complications, including drug use-associated wounds. The project will evaluate wound...
- Federal Project Grant Award Summary This Career Development Award, funded by the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), supports research to advance quality measurement and improvement in outpatient substance use disorder (SUD) treatment facilities serving Medicaid enrollees. Awarded to the Trustees of Boston University on May 1, 2026, with total obligated funding of $193,751.00 through April 30, 2031, the project delivers...
- Federal Grant Award Summary Cedars-Sinai Medical Center received a $191,070 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded June 15, 2026, with completion anticipated May 31, 2031. This K01 award supports a structured research and training program investigating the neurobehavioral mechanisms underlying prenatal opioid exposure (PODE) on infant brain and developmental trajectories. The research will deliver...
- Federal Project Grant Award Summary The National Institute on Drug Abuse (NIDA), under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded a K24 Midcareer Investigator Award in Patient-Oriented Research totaling $217,751 to Massachusetts General Hospital, effective May 1, 2026 through April 30, 2031. This award supports Dr. Scott Hadland's research program to develop and validate a quality measurement framework for youth opioid use disorder (OUD) treatment. The research...
- Federal Grant Award Summary The National Institute on Drug Abuse (NIDA) awarded a $190,825 Project Grant to The Regents of the University of Colorado, doing business as University of Colorado-Denver, effective February 1, 2026, through January 31, 2031, under the Drug Use and Addiction Research Programs (CFDA 93.279). The award funds the Improving Methadone Patient-Centered Treatment (IMPACT) implementation program, which develops and pilot-tests strategies to increase opioid treatment program...
- Federal Grant Award Summary New York University School of Medicine received a $208,331 Project Grant from the National Institute on Drug Abuse (NIDA) under the Drug Use and Addiction Research Programs (CFDA 93.279), awarded August 15, 2025, with completion targeted for July 31, 2030. This K01 Career Development Award supports Dr. Choi's research examining variations in perinatal drug toxicology screening practices across New York State hospitals. The project delivers a comprehensive, multi-level...